Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Atherosclerosis

Retrieve available abstracts of 86 articles:
HTML format

Single Articles

    June 2021
  1. PAQUETTE M, Fantino M, Bernard S, Baass A, et al
    Paternal inheritance predicts earlier cardiovascular event onset in patients with familial hypercholesterolemia.
    Atherosclerosis. 2021;329:9-13.
    PubMed     Abstract available

  2. VAN DAM-NOLEN DHK, van Dijk AC, Crombag GAJC, Lucci C, et al
    Lipoprotein(a) levels and atherosclerotic plaque characteristics in the carotid artery: The Plaque at RISK (PARISK) study.
    Atherosclerosis. 2021;329:22-29.
    PubMed     Abstract available

  3. CHO Y, Jeong Y, Seo DH, Ahn SH, et al
    Use of statin for the primary prevention of cardiovascular outcomes in elderly patients: A propensity-matched cohort study.
    Atherosclerosis. 2021;328:92-99.
    PubMed     Abstract available

    May 2021
  4. HONDA Y, Mok Y, Mathews L, Hof JRV, et al
    Psychosocial factors and subsequent risk of hospitalizations with peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study.
    Atherosclerosis. 2021 May 9. pii: S0021-9150(21)00223.
    PubMed     Abstract available

    April 2021
  5. BONETTI NR, Liberale L, Akhmedov A, Pasterk L, et al
    Long-term dietary supplementation with plant-derived omega-3 fatty acid improves outcome in experimental ischemic stroke.
    Atherosclerosis. 2021;325:89-98.
    PubMed     Abstract available

  6. METHORST R, Pasterkamp G, van der Laan SW
    Exploring the causal inference of shear stress associated DNA methylation in carotid plaque on cardiovascular risk.
    Atherosclerosis. 2021;325:30-37.
    PubMed     Abstract available

  7. TSUNEYOSHI S, Matsukuma Y, Kawai Y, Hiyamuta H, et al
    Association between geriatric nutritional risk index and stroke risk in hemodialysis patients: 10-Years outcome of the Q-Cohort study.
    Atherosclerosis. 2021;323:30-36.
    PubMed     Abstract available

    March 2021
  8. ZHANG JF, Meng X, Jing J, Pan Y, et al
    Serum calcium and long-term outcome after ischemic stroke: Results from the China National stroke registry III.
    Atherosclerosis. 2021;325:24-29.
    PubMed     Abstract available

  9. SHI F, Sun L, Kaptoge S
    Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis.
    Atherosclerosis. 2021;320:70-78.
    PubMed     Abstract available

    February 2021
  10. KISANUKI K, Muraki I, Yamagishi K, Kokubo Y, et al
    Weight change during middle age and risk of stroke and coronary heart disease: The Japan Public Health Center-based Prospective Study.
    Atherosclerosis. 2021;322:67-73.
    PubMed     Abstract available

  11. XU M, Chen R, Liu L, Liu X, et al
    Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: The Dongfeng-Tongji cohort study.
    Atherosclerosis. 2021;323:20-29.
    PubMed     Abstract available

  12. KEDHI E, Verdoia M, Suryapranata H, Damen S, et al
    Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial.
    Atherosclerosis. 2021;321:39-44.
    PubMed     Abstract available

    January 2021
  13. XIAO J, Padrick MM, Jiang T, Xia S, et al
    Acute ischemic stroke versus transient ischemic attack: Differential plaque morphological features in symptomatic intracranial atherosclerotic lesions.
    Atherosclerosis. 2021;319:72-78.
    PubMed     Abstract available

  14. MANTELLA LE, Liblik K, Johri AM
    Vascular imaging of atherosclerosis: Strengths and weaknesses.
    Atherosclerosis. 2021;319:42-50.
    PubMed     Abstract available

  15. LI HQ, Wang X, Wang HF, Zhang W, et al
    Dose-response relationship between blood pressure and intracranial atherosclerotic stenosis.
    Atherosclerosis. 2021;317:36-40.
    PubMed     Abstract available

  16. HUANG YC, Chang CC, Yeh CC, Lin CS, et al
    The protective effect of statins against pressure ulcers in stroke patients: A propensity-score matched study based on a real-world database.
    Atherosclerosis. 2021;317:22-28.
    PubMed     Abstract available

    December 2020
  17. ZDANYTE M, Wrazidlo RW, Kaltenbach S, Groga-Bada P, et al
    Predicting 1-, 3- and 5-year outcomes in patients with coronary artery disease: A comparison of available risk assessment scores.
    Atherosclerosis. 2020;318:1-7.
    PubMed     Abstract available

    November 2020
  18. PENSON PE, Banach M
    Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes.
    Atherosclerosis. 2020;316:58-65.
    PubMed     Abstract available

  19. KAUW F, de Jong PA, Takx RAP, de Jong HWAM, et al
    Effect of intravenous thrombolysis in stroke depends on pattern of intracranial internal carotid artery calcification.
    Atherosclerosis. 2020;316:8-14.
    PubMed     Abstract available

  20. KEDHI E, Delewi R, Fabris E, De Luca G, et al
    Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials.
    Atherosclerosis. 2020;315:55-61.
    PubMed     Abstract available

    October 2020
  21. BELL S, Gibson JT, Harshfield EL, Markus HS, et al
    Is periodontitis a risk factor for ischaemic stroke, coronary artery disease and subclinical atherosclerosis? A Mendelian randomization study.
    Atherosclerosis. 2020;313:111-117.
    PubMed     Abstract available

    September 2020
  22. RENU A, Blasco J, Laredo C, Llull L, et al
    Carotid stent occlusion after emergent stenting in acute ischemic stroke: Incidence, predictors and clinical relevance.
    Atherosclerosis. 2020;313:8-13.
    PubMed     Abstract available

  23. LIU X, Wu S, Song Q, Wang X, et al
    Visit-to-visit variability of lipid measurements and the risk of myocardial infarction and all-cause mortality: A prospective cohort study.
    Atherosclerosis. 2020 Sep 9. pii: S0021-9150(20)30493.
    PubMed     Abstract available

    May 2020
  24. SCHROTTMAIER WC, Mussbacher M, Salzmann M, Assinger A, et al
    Platelet-leukocyte interplay during vascular disease.
    Atherosclerosis. 2020 May 11. pii: S0021-9150(20)30232.
    PubMed     Abstract available

    April 2020
  25. LI S, Wang A, Zhang X, Wang Y, et al
    Design and validation of prehospital acute stroke triage (PAST) scale to predict large vessel occlusion.
    Atherosclerosis. 2020;306:1-5.
    PubMed     Abstract available

    March 2020
  26. YAO Y, Zhu H, Zhu L, Fang Z, et al
    A comprehensive contribution of genetic variations of the insulin-like growth factor 1 signalling pathway to stroke susceptibility.
    Atherosclerosis. 2020;296:59-65.
    PubMed     Abstract available

  27. MAZIDI M, Katsiki N, Mikhailidis DP, Banach M, et al
    Associations of serum uric acid with total and cause-specific mortality: Findings from individuals and pooling prospective studies.
    Atherosclerosis. 2020;296:49-58.
    PubMed     Abstract available

  28. ADINOLFI LE, Petta S, Fracanzani AL, Coppola C, et al
    Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study.
    Atherosclerosis. 2020;296:40-47.
    PubMed     Abstract available

  29. SIMONETTO C, Heier M, Rospleszcz S, Meisinger C, et al
    Risk for cardiovascular events responds nonlinearly to carotid intima-media thickness in the KORA F4 study.
    Atherosclerosis. 2020;296:32-39.
    PubMed     Abstract available

  30. WANG A, Dai L, Zhang N, Lin J, et al
    Oxidized low-density lipoprotein (LDL) and LDL cholesterol are associated with outcomes of minor stroke and TIA.
    Atherosclerosis. 2020;297:74-80.
    PubMed     Abstract available

  31. LIM SS, Yang YL, Chen SC, Wu CH, et al
    Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.
    Atherosclerosis. 2020;297:40-46.
    PubMed     Abstract available

  32. THEN C, Then HL, Lechner A, Thorand B, et al
    Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study.
    Atherosclerosis. 2020;297:1-7.
    PubMed     Abstract available

    February 2020
  33. HSIEH CY, Lee CH, Sung SF
    Development of a novel score to predict newly diagnosed atrial fibrillation after ischemic stroke: The CHASE-LESS score.
    Atherosclerosis. 2020;295:1-7.
    PubMed     Abstract available

    January 2020
  34. CHARACH G, Karniel E, Novikov I, Galin L, et al
    Reduced bile acid excretion is an independent risk factor for stroke and mortality: A prospective follow-up study.
    Atherosclerosis. 2020;293:79-85.
    PubMed     Abstract available

  35. MUNOZ-TORRERO JFS, Zamorano J, Rico-Martin S, Rivas MD, et al
    Proton pump inhibitors and risk for recurrent ischemic events or death in outpatients with symptomatic artery disease.
    Atherosclerosis. 2020;292:84-89.
    PubMed     Abstract available

    November 2019
  36. SATO T, Sakai K, Komatsu T, Sakuta K, et al
    Risk factors for infarct expansion are different between lacunar and giant lacunar infarction.
    Atherosclerosis. 2019;292:17-22.
    PubMed     Abstract available

    August 2019
  37. HE XW, Shi YH, Liu YS, Li GF, et al
    Increased plasma levels of miR-124-3p, miR-125b-5p and miR-192-5p are associated with outcomes in acute ischaemic stroke patients receiving thrombolysis.
    Atherosclerosis. 2019;289:36-43.
    PubMed     Abstract available

    January 2019
  38. PLANAS-BALLVE A, Crespo AM, Aguilar LM, Hernandez-Perez M, et al
    The Barcelona-Asymptomatic Intracranial Atherosclerosis study: Subclinical intracranial atherosclerosis as predictor of long-term vascular events.
    Atherosclerosis. 2019;282:132-136.
    PubMed     Abstract available

  39. MALHOTRA K, Safouris A, Goyal N, Arthur A, et al
    Association of statin pretreatment with collateral circulation and final infarct volume in acute ischemic stroke patients: A meta-analysis.
    Atherosclerosis. 2019;282:75-79.
    PubMed     Abstract available

    December 2018
  40. WAKE M, Oh A, Onishi Y, Guelfucci F, et al
    Adherence and persistence to hyperlipidemia medications in patients with atherosclerotic cardiovascular disease and those with diabetes mellitus based on administrative claims data in Japan.
    Atherosclerosis. 2018;282:19-28.
    PubMed     Abstract available

    September 2018
  41. PURROY A, Roncal C, Orbe J, Meilhac O, et al
    Matrix metalloproteinase-10 deficiency delays atherosclerosis progression and plaque calcification.
    Atherosclerosis. 2018;278:124-134.
    PubMed     Abstract available

  42. SOLBU MD, Kolset SO, Jenssen TG, Wilsgaard T, et al
    Gender differences in the association of syndecan-4 with myocardial infarction: The population-based Tromso Study.
    Atherosclerosis. 2018;278:166-173.
    PubMed     Abstract available

    August 2018
  43. CHUNG CM, Lin MS, Liu CH, Lee TH, et al
    Discontinuing or continuing statin following intracerebral hemorrhage from the view of a national cohort study.
    Atherosclerosis. 2018;278:15-22.
    PubMed     Abstract available

    July 2018
  44. WANG IK, Lien LM, Lee JT, Liu CH, et al
    Renal dysfunction increases the risk of recurrent stroke in patients with acute ischemic stroke.
    Atherosclerosis. 2018;277:15-20.
    PubMed     Abstract available

    June 2018
  45. SCHRODER J, Zethner-Moller R, Bove KB, Mygind ND, et al
    Protein biomarkers and coronary microvascular dilatation assessed by rubidium-82 PET in women with angina pectoris and no obstructive coronary artery disease.
    Atherosclerosis. 2018;275:319-327.
    PubMed     Abstract available

    April 2018
  46. TOUBOUL PJ, Labreuche J, Bruckert E, Schargrodsky H, et al
    Corrigendum to "HDL-C, triglycerides and carotid IMT: A meta-analysis of 21,000 patients with automated edge detection IMT measurement" [Atherosclerosis 232 (2014) 65-71].
    Atherosclerosis. 2018 Apr 12. pii: S0021-9150(18)30025.

  47. STOLBERG CR, Mundbjerg LH, Funch-Jensen P, Gram B, et al
    Effects of gastric bypass surgery followed by supervised physical training on inflammation and endothelial function: A randomized controlled trial.
    Atherosclerosis. 2018;273:37-44.
    PubMed     Abstract available

    March 2018
  48. WILLIAMS BA, Chagin KM, Bash LD, Boden WE, et al
    External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction.
    Atherosclerosis. 2018;272:80-86.
    PubMed     Abstract available

  49. BECATTINI C, Dentali F, Camporese G, Sembolini A, et al
    Carotid atherosclerosis and risk for ischemic stroke in patients with atrial fibrillation on oral anticoagulant treatment.
    Atherosclerosis. 2018;271:177-181.
    PubMed     Abstract available

    Total cholesterol and the risk of stroke: A double-edged sword or a blunt knife?
    Atherosclerosis. 2018;270:191-192.

    February 2018
  51. ROY J
    Stroke outcome is associated with baseline renal function: A risk factor that matters!
    Atherosclerosis. 2018;269:258-259.

  52. DONG JY, Iso H
    Reply to: "Chocolate intake in pre-menopausal women".
    Atherosclerosis. 2018;269:313.

  53. MATTIOLI AV, Farinetti A
    Chocolate intake in pre-menopausal women.
    Atherosclerosis. 2018;269:312.

    January 2018
  54. GOCMEN R, Arsava EM, Oguz KK, Topcuoglu MA, et al
    Atherosclerotic intracranial internal carotid artery calcification and intravenous thrombolytic therapy for acute ischemic stroke.
    Atherosclerosis. 2018;270:89-94.
    PubMed     Abstract available

  55. ZHONG C, Han L, Zhang Y
    Reply to: "Prognostic value of lipoprotein-associated phospholipase A2 mass for all-cause mortality and vascular events within one year after acute ischemic stroke: Methodological issues".
    Atherosclerosis. 2018;268:233-234.

    Prognostic value of lipoprotein-associated phospholipase A2 mass for all-cause mortality and vascular events within one year after acute ischemic stroke: Methodological issues.
    Atherosclerosis. 2018;268:231-232.

    December 2017
  57. NISHIHIRA K, Shibata Y, Yamashita A, Kuriyama N, et al
    Relationship between thrombus age in aspirated coronary material and mid-term major adverse cardiac and cerebrovascular events in patients with acute myocardial infarction.
    Atherosclerosis. 2017;268:138-144.
    PubMed     Abstract available

    November 2017
  58. ELHAKEEM A, Murray ET, Cooper R, Kuh D, et al
    Leisure-time physical activity across adulthood and biomarkers of cardiovascular disease at age 60-64: A prospective cohort study.
    Atherosclerosis. 2017 Nov 20. pii: S0021-9150(17)31389.
    PubMed     Abstract available

    September 2017
  59. SAITO I, Yamagishi K, Kokubo Y, Yatsuya H, et al
    Association of high-density lipoprotein cholesterol concentration with different types of stroke and coronary heart disease: The Japan Public Health Center-based prospective (JPHC) study.
    Atherosclerosis. 2017;265:147-154.
    PubMed     Abstract available

    August 2017
  60. CHU LM, Liu CC, Yeh CC, Chang YC, et al
    Increased diabetes risk and interaction with social and medical events in patients upon stroke: Two nationwide studies.
    Atherosclerosis. 2017;265:87-92.
    PubMed     Abstract available

    July 2017
  61. HOLMLUND A, Lampa E, Lind L
    Oral health and cardiovascular disease risk in a cohort of periodontitis patients.
    Atherosclerosis. 2017;262:101-106.
    PubMed     Abstract available

  62. TOUTOUZAS K, Benetos G, Koutagiar I, Barampoutis N, et al
    Noninvasive detection of increased carotid artery temperature in patients with coronary artery disease predicts major cardiovascular events at one year: Results from a prospective multicenter study.
    Atherosclerosis. 2017;262:25-30.
    PubMed     Abstract available

  63. ZHANG Q, Wang A, Zhang S, Li N, et al
    Asymptomatic polyvascular disease and the risks of cardiovascular events and all-cause death.
    Atherosclerosis. 2017;262:1-7.
    PubMed     Abstract available

    June 2017
  64. GRAM AS, Bladbjerg EM, Quist JS, Petersen MB, et al
    Anti-inflammatory effects of active commuting and leisure time exercise in overweight and obese women and men: A randomized controlled trial.
    Atherosclerosis. 2017 Jun 28. pii: S0021-9150(17)31172.
    PubMed     Abstract available

  65. TAKAMURA TA, Tsuchiya T, Oda M, Watanabe M, et al
    Circulating malondialdehyde-modified low-density lipoprotein (MDA-LDL) as a novel predictor of clinical outcome after endovascular therapy in patients with peripheral artery disease (PAD).
    Atherosclerosis. 2017;263:192-197.
    PubMed     Abstract available

  66. LINDSKOG JONSSON A, Hallenius FF, Akrami R, Johansson E, et al
    Bacterial profile in human atherosclerotic plaques.
    Atherosclerosis. 2017;263:177-183.
    PubMed     Abstract available

    May 2017
  67. OIKAWA K, Kato T, Oura K, Narumi S, et al
    Preoperative cervical carotid artery contrast-enhanced ultrasound findings are associated with development of microembolic signals on transcranial Doppler during carotid exposure in endarterectomy.
    Atherosclerosis. 2017;260:87-93.
    PubMed     Abstract available

  68. DONG JY, Iso H, Yamagishi K, Sawada N, et al
    Chocolate consumption and risk of stroke among men and women: A large population-based, prospective cohort study.
    Atherosclerosis. 2017;260:8-12.
    PubMed     Abstract available

    April 2017
  69. POTT J, Burkhardt R, Beutner F, Horn K, et al
    Genome-wide meta-analysis identifies novel loci of plaque burden in carotid artery.
    Atherosclerosis. 2017;259:32-40.
    PubMed     Abstract available

    March 2017
    Ischaemic stroke and liver fibrosis.
    Atherosclerosis. 2017 Mar 22. pii: S0021-9150(17)30130.

    January 2017
  71. TUTTOLOMONDO A, Casuccio A, Della Corte V, Maida C, et al
    Endothelial function and arterial stiffness indexes in subjects with acute ischemic stroke: Relationship with TOAST subtype.
    Atherosclerosis. 2017;256:94-99.
    PubMed     Abstract available

    September 2016
  72. GUO XY, Li N, Du X, Bai R, et al
    Atrial fibrillation is associated with an increased risk of myocardial infarction: Insights from a meta-analysis.
    Atherosclerosis. 2016;254:1-7.
    PubMed     Abstract available

  73. PIEPOLI MF, Hoes AW, Agewall S, Albus C, et al
    2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by represen
    Atherosclerosis. 2016;252:207-74.

    August 2016
  74. ISHIZUKA K, Hoshino T, Shimizu S, Shirai Y, et al
    Brachial-ankle pulse wave velocity is associated with 3-month functional prognosis after ischemic stroke.
    Atherosclerosis. 2016;255:1-5.
    PubMed     Abstract available

    July 2016
  75. VISSERS LE, Waller MA, van der Schouw YT, Hebert JR, et al
    The relationship between the dietary inflammatory index and risk of total cardiovascular disease, ischemic heart disease and cerebrovascular disease: Findings from an Australian population-based prospective cohort study of women.
    Atherosclerosis. 2016 Jul 30. pii: S0021-9150(16)31230.
    PubMed     Abstract available

    June 2016
  76. MENZEL J, di Giuseppe R, Biemann R, Wittenbecher C, et al
    Omentin-1 and risk of myocardial infarction and stroke: Results from the EPIC-Potsdam cohort study.
    Atherosclerosis. 2016 Jun 2. pii: S0021-9150(16)30243.
    PubMed     Abstract available

    May 2016
  77. MENEGAUT L, Masson D, Abello N, Denimal D, et al
    Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients.
    Atherosclerosis. 2016 May 4. pii: S0021-9150(16)30164.
    PubMed     Abstract available

  78. DE CATERINA R, Salvatore T, Marchioli R
    Cholesterol-lowering interventions and stroke: Insights from IMPROVE-IT.
    Atherosclerosis. 2016;248:216-8.
    PubMed     Abstract available

    April 2016
  79. SKAGEN K, Troseid M, Ueland T, Holm S, et al
    The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
    Atherosclerosis. 2016;247:64-9.
    PubMed     Abstract available

    March 2016
  80. PETERS SA, Singhateh Y, Mackay D, Huxley RR, et al
    Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: A systematic review and meta-analysis.
    Atherosclerosis. 2016;248:123-131.
    PubMed     Abstract available

  81. CUI R, Iso H, Yamagishi K, Saito I, et al
    Trends in the proportions of stroke subtypes and coronary heart disease in the Japanese men and women from 1995 to 2009.
    Atherosclerosis. 2016;248:219-223.
    PubMed     Abstract available

  82. ERLOV T, Cinthio M, Edsfeldt A, Segstedt S, et al
    Determining carotid plaque vulnerability using ultrasound center frequency shifts.
    Atherosclerosis. 2016;246:293-300.
    PubMed     Abstract available

  83. BANG OY, Chung JW, Ryoo S, Moon GJ, et al
    Brain microangiopathy and macroangiopathy share common risk factors and biomarkers.
    Atherosclerosis. 2016;246:71-7.
    PubMed     Abstract available

  84. LAZO-PORRAS M, Bernabe-Ortiz A, Malaga G, Gilman RH, et al
    Low HDL cholesterol as a cardiovascular risk factor in rural, urban, and rural-urban migrants: PERU MIGRANT cohort study.
    Atherosclerosis. 2016;246:36-43.
    PubMed     Abstract available

    January 2016
  85. NAKAMURA M, Uemura T, Saiki R, Sakamoto A, et al
    Toxic acrolein production due to Ca(2+) influx by the NMDA receptor during stroke.
    Atherosclerosis. 2016;244:131-7.
    PubMed     Abstract available

    October 2015
  86. PURI R, Nissen SE, Menon V, Shao M, et al
    Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS.
    Atherosclerosis. 2015;243:553-559.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.